- Home
- ZURA vs ASPI Comparison
ZURA vs ASPI Comparison
Compare ZURA & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZURA | ASPI |
|---|---|---|
| Founded | 2022 | 2021 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 595.9M | 639.3M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | ZURA | ASPI |
|---|---|---|
| Price | $5.99 | $4.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | $11.78 | ★ $12.00 |
| AVG Volume (30 Days) | 482.0K | ★ 3.9M |
| Earning Date | 05-07-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,144,226.00 |
| Revenue This Year | N/A | $108.31 |
| Revenue Next Year | N/A | $403.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 857.04 |
| 52 Week Low | $0.99 | $3.92 |
| 52 Week High | $7.25 | $14.49 |
Technical Indicators
Market Signals| Indicator | ZURA | ASPI |
|---|---|---|
| Relative Strength Index (RSI) | 42.39 | 37.38 |
| Support Level | $5.62 | N/A |
| Resistance Level | $6.99 | $6.20 |
| Average True Range (ATR) | 0.50 | 0.54 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 5.19 | 0.28 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.